An Overview and Update of Femorofemoral Crossover Bypass Surgery as an Extra-Anatomic Bypass Procedure

Abstract

Femorofemoral crossover bypass is a surgical arterial revascularization modality which is commonly performed for unilateral aortoiliac occlusive disease. It is primarily applied to patients with intermittent claudication or critical limb ischemia in whom underlying anatomic constraints rule out endovascular means of restoring in-line flow and those who do not qualify for anatomic reconstruction due to the comorbid conditions that preclude a more invasive open surgical approach. This surgical procedure may be also used as a complementary component of endovascular repair of abdominal aortic aneurysms when one aortoiliac arterial system is occluded to ensure exclusion of the aortic aneurysm. This review represents the current status of femorofemoral crossover bypass surgery as an extra-anatomic bypass procedure.

Keywords

femorofemoral crossover bypass - extra-anatomic bypass surgery - overview - update

• References

• 1 Haigh K, Bingley J, Golledge J, Walker PJ. Peripheral arterial disease - screening in general practice. Aust Fam Physician 2013; 42 (06) 391-395
• 2 Es MU, Senol S, Yuksel A. Is hemoglobin A1c a valuable parameter in non-diabetic patients with peripheral arterial disease?. Acta Med Mediter 2016; 32: 911-915
• 3 Welten GM, Schouten O, Chonchol M. , et al. Prognosis of patients with peripheral arterial disease. J Cardiovasc Surg (Torino) 2009; 50 (01) 109-121
• 4 Ramos R, Quesada M, Solanas P. , et al; REGICOR Investigators. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009; 38 (03) 305-311
• 5 Lawall H, Huppert P, Espinola-Klein C, Rümenapf G. The diagnosis and treatment of peripheral arterial vascular disease. Dtsch Arztebl Int 2016; 113 (43) 729-736
• 6 Au TB, Golledge J, Walker PJ, Haigh K, Nelson M. Peripheral arterial disease - diagnosis and management in general practice. Aust Fam Physician 2013; 42 (06) 397-400
• 7 Aronow WS. Lower extremity peripherals arterial disease treatment. SRL Vasc Med 2015; 1: 1-6
• 8 Weitz JI, Byrne J, Clagett GP. , et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94 (11) 3026-3049
• 9 Johnson WC, Lee KK. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141. J Vasc Surg 1999; 30 (06) 1077-1083
• 10 Mingoli A, Sapienza P, Feldhaus RJ, Di Marzo L, Burchi C, Cavallaro A. Femorofemoral bypass grafts: factors influencing long-term patency rate and outcome. Surgery 2001; 129 (04) 451-458
• 11 Pai M, Handa A, Hands L, Collin J. Femoro-femoral arterial bypass is an effective and durable treatment for symptomatic unilateral iliac artery occlusion. Ann R Coll Surg Engl 2003; 85 (02) 88-90
• 12 Lee CJ, Morasch MD. Femorofemoral bypass. Aug 30, 2016. Available at: http://emedicine.medscape.com/article/1830260-overview [accessed May 21, 2017]
• 13 Rehring TF, Brewster DC, Cambria RP. , et al. Utility and reliability of endovascular aortouniiliac with femorofemoral crossover graft for aortoiliac aneurysmal disease. J Vasc Surg 2000; 31 (06) 1135-1141
• 14 Heredero AF, Stefanov S, del Moral LR. , et al. Long-term results of femoro-femoral crossover bypass after endovascular aortouniiliac repair of abdominal aortic and aortoiliac aneurysms. Vasc Endovascular Surg 2008; 42 (05) 420-426
• 15 Elkassaby M, Alawy M, Ali MZ, Tawfick WA, Sultan S. Aorto-uni-iliac stent grafts with and without crossover femorofemoral bypass for treatment of abdominal aortic aneurysms: a parallel observational comparative study. Int J Vasc Med 2015; 2015 (15) 962078
• 16 Oudot J, Beaconsfield P. Thrombosis of the aortic bifurcation treated by resection and homograft replacement; report of five cases. AMA Arch Surg 1953; 66 (03) 365-374
• 17 Freeman NE, Leeds FH. Operations on large arteries; application of recent advances. Calif Med 1952; 77 (04) 229-233
• 18 McCaughan JJ, Kahn SF. Cross-over graft for unilateral occlusive disease of the ilio-femoral arteries. Ann Surg 1960; 151 (01) 26-28
• 19 Vetto RM. The treatment of unilateral iliac artery obstruction with a transabdominal, subcutaneous, femorofemoral graft. Surgery 1962; 52: 343-345
• 20 Vetto RM. The femorofemoral shunt. An appraisal. Am J Surg 1966; 112 (02) 162-165
• 21 Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg 2005; 30 (04) 376-380
• 22 Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg 2005; 92 (05) 565-569
• 23 Mii S, Eguchi D, Takenaka T, Maehara S, Tomisaki S, Sakata H. Role of femorofemoral crossover bypass grafting for unilateral iliac atherosclerotic disease: a comparative evaluation with anatomic bypass. Surg Today 2005; 35 (06) 453-458
• 24 Eiberg JP, Røder O, Stahl-Madsen M. , et al. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial. Eur J Vasc Endovasc Surg 2006; 32 (04) 431-438
• 25 Stone PA, Armstrong PA, Bandyk DF. , et al. Duplex ultrasound criteria for femorofemoral bypass revision. J Vasc Surg 2006; 44 (03) 496-502
• 26 Hertzer NR, Bena JF, Karafa MT. A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease. J Vasc Surg 2007; 45 (03) 527-535 , discussion 535
• 27 Thuijls G, van Laake LW, Lemson MS, Kitslaar PJ. Usefulness and applicability of femorofemoral crossover bypass grafting. Ann Vasc Surg 2008; 22 (05) 663-667
• 28 Ricco JB, Probst H. ; French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg 2008; 47 (01) 45-53 , discussion 53–54
• 29 Lindholt JS, Gottschalksen B, Johannesen N. , et al. The Scandinavian Propaten(®) trial - 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses - a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg 2011; 41 (05) 668-673
• 30 Huded CP, Goodney PP, Powell RJ. , et al. The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice. J Vasc Surg 2012; 55 (03) 739-745 , discussion 744–745
• 31 Rinckenbach S, Guelle N, Lillaz J, Al Sayed M, Ritucci V, Camelot G. Femorofemoral bypass as an alternative to a direct aortic approach in daily practice: appraisal of its current indications and midterm results. Ann Vasc Surg 2012; 26 (03) 359-364
• 32 Ascher E, Veith FJ. Extra-anatomic bypasses. In: Ascher E, Hollier LH, Strandness DE, Towne JB. , eds. Haimovici's Vascular Surgery. 5th ed. Malden, MA: Blackwell Publishing, Inc.; 2004: 625-636 , Chapter 51
• 33 Saçar M, Önem G, Işıklı OY. , et al. Our intermediate and long-term results in the extra-anatomic bypass surgery. Pamukkale Med J 2011; 4: 58-65
• 34 Lin PH, Bush RL, Conklin BS, Chaikof EL, Lumsden AB. Percutaneous bedside femorofemoral bypass grafting for acute limb ischemia caused by intra-aortic balloon pump. J Vasc Surg 2002; 35 (03) 592-594
• 35 Sieńko J, Tejchman K, Cnotliwy M, Falkowski A, Nowacki M, Ostrowski M. Crossed bypass femoro-femoralis in patient with external iliac artery occlusion in the course of septic hemorrhage after renal graft explantatation. Ann Transplant 2006; 11 (03) 12-14
• 36 Demir T, Ergenoglu MU, Tanrikulu N, Ekinci A, Demirsoy E. Renal allograft dysfunction due to iliac artery occlusion: cross-over femoro-femoral bypass saves the day. Turkiye Klinikleri J Int Med Sci 2008; 4: 1
• 37 Thapar A, Dindyal S, Refson J. The ‘two toe’ technique for femorofemoral bypass. Ann R Coll Surg Engl 2014; 96 (01) 79
• 38 Chatterjee S, Bashir R, Lakhter V, O'Murchu B, O'Neill B, Aggarwal V. Case of percutaneous extracorporeal femoro-femoral bypass for acute limb ischemia from large bore access. JACC Cardiovasc Interv 2017; 10 (12) e109-e110
• 39 Kizner L, Flottmann C, Horstkotte D, Gummert J. Bilateral antegrade perfusion of the superficial femoral artery to prevent limb ischaemia during combined use of Impella CP left ventricular assist device and extracorporeal life support. Interact Cardiovasc Thorac Surg 2016; 23 (02) 335-337
• 40 Lindholt JS, Houlind K, Gottschalksen B. , et al. Five-year outcomes following a randomized trial of femorofemoral and femoropopliteal bypass grafting with heparin-bonded or standard polytetrafluoroethylene grafts. Br J Surg 2016; 103 (10) 1300-1305
• 41 Pereira de Godoy JM. Surgical mortality in critical ischemia. Glob J Angiol 2016; 2: 8-10
• 42 Criado E, Burnham SJ, Tinsley Jr EA, Johnson Jr G, Keagy BA. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg 1993; 18 (03) 495-504 , discussion 504–505
• 43 Schneider JR, Besso SR, Walsh DB, Zwolak RM, Cronenwett JL. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results. J Vasc Surg 1994; 19 (01) 43-55 , discussion 55–57
• 44 Capoccia L, Riambau V, da Rocha M. Is femorofemoral crossover bypass an option in claudication?. Ann Vasc Surg 2010; 24 (06) 828-832
• 45 Aburahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg 2001; 33 (2, Suppl): S93-S99
• 46 Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass? Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg 1996; 24 (03) 363-369 , discussion 369–370
• 47 Shah RM, Peer RM, Upson JF, Ricotta JJ. Donor iliac angioplasty and crossover femorofemoral bypass. Am J Surg 1992; 164 (03) 295-298
• 48 Lopez-Galarza LA, Ray LI, Rodriguez-Lopez J, Diethrich EB. Combined percutaneous transluminal angioplasty, iliac stent deployment, and femorofemoral bypass for bilateral aortoiliac occlusive disease. J Am Coll Surg 1997; 184 (03) 249-258
• 49 Melliere D, Cron J, Allaire E, Desgranges P, Becquemin JP. Indications and benefits of simultaneous endoluminal balloon angioplasty and open surgery during elective lower limb revascularization. Cardiovasc Surg 1999; 7 (02) 242-246
• 50 Kalman PG, Hosang M, Johnston KW, Walker PM. The current role for femorofemoral bypass. J Vasc Surg 1987; 6 (01) 71-76
• 51 Self SB, Richardson JD, Klamer TW, Kaebnick HW, Lambert GE, Mitchell RA. Utility of femorofemoral bypass. Comparison of results with indications for operation. Am Surg 1991; 57 (09) 602-606
• 52 Nazzal MM, Hoballah JJ, Jacobovicz C. , et al. A comparative evaluation of femorofemoral crossover bypass and iliofemoral bypass for unilateral iliac artery occlusive disease. Angiology 1998; 49 (04) 259-265
• 53 Mingoli A, Sapienza P, Feldhaus RJ, Di Marzo L, Burchi C, Cavallaro A. Comparison of femorofemoral and aortofemoral bypass for aortoiliac occlusive disease. J Cardiovasc Surg (Torino) 2001; 42 (03) 381-387
• 54 Vartanian SM, Conte MS. Surgical intervention for peripheral arterial disease. Circ Res 2015; 116 (09) 1614-1628
• 55 Berce M, Sayers RD, Miller JH. Femorofemoral crossover grafts for claudication: a safe and reliable procedure. Eur J Vasc Endovasc Surg 1996; 12 (04) 437-441
• 56 Karaca K, Ozeren M, Aytacoglu BN, Vezir O, Sucu N. Ringed reinforced polytetrafluoroethylene sheltered saphenous vein graft for femorofemoral bypass in critical leg ischemia with limited distal run off. Turk J Vasc Surg 2014; 23: 207-211